Challenges in treating prosthetic valve endocarditis

JAMA Internal Medicine

Volumn 173, Issue 16, 2013, Pages 1504-1505

  Bolger, Ann F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; COMORBIDITY; FUNCTIONAL STATUS; HEART FAILURE; HEART VALVE PROSTHESIS; HEART VENTRICLE ARRHYTHMIA; HOSPITAL INFECTION; HUMAN; MEDICAL SOCIETY; NOTE; PRIORITY JOURNAL; PROPENSITY SCORE; PROSTHESIS INFECTION; PROSTHETIC VALVE ENDOCARDITIS; SURVIVOR;

ENDOCARDITIS, BACTERIAL; FEMALE; HEART VALVE PROSTHESIS; HOSPITAL MORTALITY; HUMANS; MALE; PROSTHESIS-RELATED INFECTIONS;

EID: 84883816084     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.7020     Document Type: Note

References (7)

1. Kang DH, Kim YJ, Kim SH, et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med. 2012;366(26):2466-2473.
2. Tleyjeh IM, Kashour T, Zimmerman V, Steckelberg JM, Wilson WR, Baddour LM. The role of valve surgery in infective endocarditis management: a systematic review of observational studies that included propensity score analysis. Am Heart J. 2008;156(5):901-909.
3. Lalani T, Cabell CH, Benjamin DK, et al International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias. Circulation. 2010;121(8):1005-1013.
4. Lalani T, Chu VH, Park LP, et al International Collaboration on Endocarditis-Prospective Cohort Study Investigators. In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis [published online July 15, 2013]. JAMA Intern Med. doi:10.1001/jamainternmed. 2013.8203.
5. Habib G, Hoen B, Tornos P, et al ESC Committee for Practice Guidelines; Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J. 2009;30(19):2369-2413.
6. Bonow RO, Carabello BA, Chatterjee K, et al American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease); Society of Cardiovascular Anesthesiologists. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J AmColl Cardiol. 2006;48(3):e1-e148.
7. Kiefer T, Park L, Tribouilloy C, et al. Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA. 2011;306(20):2239-2247.